Skip to main content

Advertisement

Log in

Degradomics: Systems biology of the protease web. Pleiotropic roles of MMPs in cancer

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

The major role of matrix metalloproteinases (MMPs) is for homeostatic regulation of the extracellular environment, not simply to degrade matrix as their name suggests. We designed and printed a dedicated, focused DNA microarray, the CLIP-CHIPTM, that enables the analysis of every human and murine protease, protease homologue and inhibitor on a system-wide basis in cancer. We have also developed novel proteomic approaches to identify cleaved substrates of proteases in complex milieu. Isotope coded affinity tag (ICAT) and iTRAQ labeling of conditioned medium proteins secreted by MDA-MB-231 breast carcinoma cells and Mmp2 -/- murine fibroblasts transfected with protease (MT1-MMP or active MMP-2) or their inactive mutant forms enabled quantitative proteomics to be performed. Comparison of the relative abundance ratios of identical peptides from the two samples identified proteins in the conditioned medium that may have been degraded (low ratios) and those that were shed from the cell membrane (high ratios). MS/MS was used to sequence and identify the potential substrates. These analyses have revealed a plethora of new bioactive substrates and biological roles for MMPs. Biochemical confirmation of cleavage of the potential substrates was performed and the cleavage sites identified by MALDI-TOF. In these studies we discovered and confirmed that CTGF, galectin-1, death receptor-6, HSP90α, procollagen C-proteinase enhancer protein, the chemokine fractalkine, and cystatin C were novel MT1-MMP or MMP-2 substrates. These sophisticated cellular control functions highlight new intervention points in multiple pathways to treat early stage cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

MMP:

matrix metalloproteinase

MMPI:

matrix metalloproteinase small molecule inhibitor drugs

MT-MMP:

membrane type-MMP

ICAT:

isotope coded affinity tag

MD-LC:

multidimensional liquid chromatography

MS:

mass spectrometry

MS/MS:

tandem mass spectrometry

References

  1. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J: Genes that mediate breast cancer metastasis to lung. Nature 436: 518–524, 2005

    Article  PubMed  CAS  Google Scholar 

  2. Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massague J: Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 115: 44–55, 2005

    Article  PubMed  CAS  Google Scholar 

  3. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, Werb Z, Bissell MJ: Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436: 123–127, 2005

    Article  PubMed  CAS  Google Scholar 

  4. Weigelt B, Peterse JL, van 't Veer LJ: Breast cancer metastasis: Markers and models. Nat Rev Cancer 5: 591–602, 2005

    Article  PubMed  CAS  Google Scholar 

  5. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530–536, 2002

    Article  Google Scholar 

  6. Kruger A, Arlt MJ, Gerg M, Kopitz C, Bernardo MM, Chang M, Mobashery S, Fridman R: Antimetastatic activity of a novel mechanism-based gelatinase inhibitor. Cancer Res 65: 3523–3356, 2005

    Article  PubMed  Google Scholar 

  7. Bramhall SR, Schulz J, Nemunaitis J, Brown PD, Baillet M, Buckels JA: A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer. Br J Cancer 87: 161–167, 2002

    Article  PubMed  CAS  Google Scholar 

  8. Overall CM, López-Otin C: Strategies for MMP inhibition in cancer: Innovations for the post-trial era. Nat Rev Cancer 2: 657–672, 2002

    Article  PubMed  CAS  Google Scholar 

  9. Coussens LM, Fingleton B, Matrisian LM: Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science 295: 2387–2392, 2002

    Article  PubMed  CAS  Google Scholar 

  10. Fingleton B: Matrix metalloproteinase inhibitors for cancer therapy: The current situation and future prospects. Expert Opin Ther Targets 7: 385–397, 2003

    Article  PubMed  CAS  Google Scholar 

  11. Overall CM, Kleifeld O: Validating MMPs as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6: 227–239, 2006

    Article  PubMed  CAS  Google Scholar 

  12. López-Otin C, Overall CM: Protease degradomics: A new challenge for proteomics. Nat Rev Mol Cell Biol 3: 509–519, 2002

    Article  PubMed  Google Scholar 

  13. Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161–174, 2002

    Article  PubMed  CAS  Google Scholar 

  14. McCawley LJ, Matrisian LM: Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 13: 534–540, 2001

    Article  PubMed  CAS  Google Scholar 

  15. Overall CM: Molecular determinants of metalloproteinase substrate specificity: Matrix metalloproteinase substrate binding domains, modules, and exosites. Mol Biotechnol 22: 51–86, 2002

    Article  PubMed  CAS  Google Scholar 

  16. Parks WC, Wilson CL, López-Boado: Matrix Metalloproteinases as Modulators of Inflammation and Innate Immunity. Nature Rev Immunol 4: 617–629, 2004

    Article  CAS  Google Scholar 

  17. Overall CM, Blobel C: In preparation, 2006

  18. Balbin M, Fueyo A, Tester AM, Pendas AM, Pitiot AS, Astudillo A, Overall CM, Shapiro SD, Lopez-Otin C: Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 35: 252–257, 2003

    Article  PubMed  CAS  Google Scholar 

  19. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C: Human and mouse proteases: A comparative genomic approach. Nat Rev Genet 4: 544–558, 2003

    Article  PubMed  CAS  Google Scholar 

  20. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67–68, 1980

    Article  PubMed  CAS  Google Scholar 

  21. Nagase H, Woessner JF: J Biol Chem 274: 21491–21494, 1999

    Article  PubMed  CAS  Google Scholar 

  22. Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D: Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284: 808–812, 1999

    Article  PubMed  CAS  Google Scholar 

  23. O'Reilly MS, Holmgren L, Chen C, Folkman J: Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 2: 689–692, 1996

    Article  PubMed  Google Scholar 

  24. Tam EM, Morrison CJ, Wu YI, Stack MS, Overall CM: Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc Natl Acad Sci USA 101: 6917–6922, 2004

    Article  PubMed  CAS  Google Scholar 

  25. McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, Overall CM: Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289: 1202–1206, 2000

    Article  PubMed  CAS  Google Scholar 

  26. Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM: Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia 3: 459–468, 2001

    Article  PubMed  CAS  Google Scholar 

  27. Overall CM, Kleifeld O: Towards Third Generation Matrix Metalloproteinase Inhibitors for Cancer Therapy. Brit J Cancer 94: 941–946, 2006

    Article  PubMed  CAS  Google Scholar 

  28. Abersold R, Mann M: Mass spectrometry-based proteomics. Nature 422: 198–207, 2003

    Article  Google Scholar 

  29. De Leenheer AP, Thienpont LM: Application of isotope dilution-mass spectrometry in clinical chemistry, pharmacokinetics, and toxicology. Mass Spectrom Rev 11: 249–307, 1992

    Article  Google Scholar 

  30. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R: Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17: 994–999, 1999

    Article  PubMed  CAS  Google Scholar 

  31. Butler G, Kappelhof R, Overall CM: In preparation, 2006

  32. Dean RA, Overall CM: In preparation, 2006

  33. Tam EM, Moore TR, Butler GS, Overall CM: Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): The differential roles of the MMP hemopexin C domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities. J Biol Chem 279: 43336–44344, 2004

    Article  PubMed  CAS  Google Scholar 

  34. DeSouza L, Diehl G, Rodrigues MJ, Guo J, Romaschin AD, Colgan TJ, Siu KW: Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J Proteome Res 4: 377–386, 2005

    Article  PubMed  CAS  Google Scholar 

  35. McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall CM: Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100: 1160–1167, 2002

    PubMed  CAS  Google Scholar 

  36. McQuibban GA, Butler GS, Gong J-H, Bendall L, Power C, Clark-Lewis I, Overall CM: Matrix Metalloproteinase Activity Inactivates the Chemokine Stromal-Cell Derived Factor-1. J Biol Chem 276: 43503–43508, 2001

    Article  PubMed  CAS  Google Scholar 

  37. Overall CM: Dilating the degradome: Matrix metalloproteinase-2 cuts to the heart of the matter. Biochem J 383: e5–e7, 2004

    Article  PubMed  CAS  Google Scholar 

  38. Sodek J, Overall CM. Matrix degradation in hard and soft connective tissues. In: Davidovitch Z, ed. The Biological Mechanisms of Tooth Eruption and Root Resorption. Birmingham: EBSCO Media; 1988: 303–311

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christopher M. Overall.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Overall, C.M., Dean, R.A. Degradomics: Systems biology of the protease web. Pleiotropic roles of MMPs in cancer. Cancer Metastasis Rev 25, 69–75 (2006). https://doi.org/10.1007/s10555-006-7890-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10555-006-7890-0

Keywords

Navigation